Articles

The announcement of a Life Science Strategy from the European Commission [2 July] includes action to address long-standing issues that have been hampering the region’s competitiveness and preventing European patients access the latest advances in treatment. The Strategy represents a very welcome step-forward for life science companies operating in Europe.
Brussels, Thursday 3 July, 2025 The announcement of a Life Science Strategy from the European Commission [2 July] includes action to address long-standing issues that have been hampering the region’s competitiveness and preventing European patients access the latest advances in treatment. The Strategy represents a very welcome step-forward for life science companies operating in Europe. The focus on making it easier to conduct clinical tri…

"The Residence" will bring together psychiatric expertise, psychological care, holistic and complimentary therapies alongside cutting-edge technology - and, set in a prestigious London location, close to the stunning and serene green space of Richmond Park, a leading addiction expert has already hailed the new service as "a space of safety and hope, where people can focus entirely on their wellbeing, free from outside pressure”
Priory - the UK’s largest independent provider of mental health, addiction and adult social care services - is set to unveil The Residence – a ground-breaking new recovery “experience” set to redefine privacy and clinical excellence in mental health and addiction care. Located in a private wing of the prestigious Priory Hospital Roehampton, South-West London, The Res…

Stefan Oelrich, President of Bayer’s Pharmaceuticals Division has been elected as the new President of the European Federation of Pharmaceutical Industries and Associations (EFPIA) with Teresa Graham, CEO of Roche Pharmaceuticals and Carlos Gallardo, Chairman and CEO of Almirall as first and second Vice Presidents.
Brussels, 30 June Stefan Oelrich, President of Bayer’s Pharmaceuticals Division has been elected as the new President of the European Federation of Pharmaceutical Industries and Associations (EFPIA) with Teresa Graham, CEO of Roche Pharmaceuticals and Carlos Gallardo, Chairman and CEO of Almirall as first and second Vice Presidents. The new team told a press conference in Brussels that a rapidly changing geopolitical environment is reshaping the life sciences playing field – and…

ePRO transforms clinical trials by replacing paper diaries—improving patient compliance, reducing data queries, and enabling real-time digital data capture.
ePRO isn’t just digitized data collection. It’s real-time, structured, regulatory-grade intelligence, designed to enhance compliance, cut down queries, and keep patients engaged. Despite operating in a digitally driven world, many clinical trials continue to rely on old-fashioned paper diaries to collect patient-reported data. As recently as 2018, nearly half of all studies capturing patient outcomes were still using paper. And that dependence hasn’t vanished overnight. Paper diaries come with known risks: missing data, unreadable handwriting, and “parking lot compliance”, when patients rush to fill in days of entries just before a sit…

An overview of alternative microbial hosts, such as E. coli, B. subtilis, Pichia, and S. cerevisiae, for recombinant bioactive production: Benefits and industrial use cases.
An Overview of Alternative Microbial Hosts for Recombinant Bioactive Production: Benefits and Industrial Use Cases Selecting the right microbial host is a major step for any biotechnology project, whether you are producing food-grade enzymes, pharmaceutical ingredients or industrial bioproducts. Your choice of production host can affect your project’s yield, product quality, scalability and regulatory approval with administrations such as the FDA. In this article, we share how to navigate these choices while analysing the advantages and use cases of our four IsoChassisTM microbial hosts. These strains include&…

Homogeneous immunoassays offer quick results without a separation step, while heterogeneous assays like ELISA require multiple steps but provide higher sensitivity and specificity. Choosing between them depends on your application—rapid screening or precise diagnostics.
Immunoassays are biochemical tests used to detect the presence or concentration of an analyte in a biological sample via an antibody-antigen reaction. They are widely used to perform screening and semi-quantitative analysis across various fields. These assays offer high sensitivity and specificity by using the unique binding affinity between antibodies and target molecules. Depending on the assay design, immunoassays can provide qualitative, semi quantitative and fully quantitative results. Immunoassays are also classified b…

Cardio Connect Healthcare Network, led by Dr. A. Fahoum, offers expert cardiology and internal medicine care in St. Albert, Alberta. With over 20 years of experience in Canada and the U.S., Dr. Fahoum specializes in heart disease, chronic conditions, and geriatric care. The clinic offers comprehensive diagnostics, including ECG, stress testing, Holter monitoring, sleep apnea testing, and more—all under one roof. Focused on personalised, compassionate care, Cardio Connect aims to build lasting relationships based on trust, clarity, and patient-first treatment.
Hello and welcome! I’m Dr. A. Fahoum, and I’m honoured to introduce myself and my clinic “Cardio Connect Healthcare Network”, located in the heart of St. Albert, Alberta. I founded this clinic with one goal in mind: to provide high-qua…

Human Health Risk Assessments (HHRAs) are a key aspect of the toxicology toolbox and apply to multiple industries be it tobacco, pharmaceutical, food or cosmetics, and are also a key part of occupational safety. They are often required for regulatory clearance and are an essential aspect of a product’s regulatory file. There are many phases required to support a HHRA including Hazard Assessment, Quantitative Risk Assessments (QRAs) and Risk Characterisation. Here, Dean Hatt, Senior Toxicology Consultant at testing and regulatory partner Broughton, examines what the assessments involve, and outlines the nuances across the different industries.
Human Health Risk Assessments (HHRAs) are a key aspect of the toxicology toolbox and apply to multiple industries be it tobacco, pharmaceutical, food…

As the NHS battles record diagnostic backlogs and rising patient demand, the radiology workforce is at breaking point. By 2028, the UK is expected to face a shortfall of 3,670 radiologists - a gap of 40%. With long training timelines unable to keep pace with growing diagnostic demand, healthcare leaders are turning to technologies such as AI and automation to support radiologists, boost productivity, and improve the patient and employee experience. In his latest article, Mark Hitchman, Managing Director at Canon Medical Systems UK, explores the issue in detail, the factors contributing to the shortage, long-term plans to resolve it, and how AI is playing a critical role in easing the strain.
Paving the way for long-term recovery: How can technology help solve the radiology workforce sh…

This article discusses the significance, applications, and benefits of biotinylated nucleotides in the realms of research and diagnostics.
Biotinylated nucleotides have emerged as a powerful tool in molecular biology, enabling researchers to explore genetic materials with unprecedented precision and sensitivity. These modified nucleotides, attached to the vitamin biotin, facilitate a variety of applications, including nucleic acid labeling, detection, and manipulation.   What Are Biotinylated Nucleotides? Biotinylated nucleotides are nucleotide molecules that have been chemically modified to include a biotin group -- a small, water-soluble vitamin known for its strong affinity for avidin or streptavidin. This affinity allows biotinylated nucleotides to be easily captured and detec…

This article delves into the significance, techniques, and applications of microbial genome editing services, illustrating their transformative impact on modern science.
Innovation in biotechnology has reached new heights with the advancement of microbial genome editing services. These services enable researchers and industries to modify the genetic makeup of microorganisms, such as bacteria and yeast, with remarkable precision. As a result, microbial genome editing has become a cornerstone in various fields, including agriculture, medicine, and environmental science.   Significance of Microbial Genome Editing Microorganisms serve as vital components in numerous biological processes, acting as workhorses for fermentation, bioremediation, and the production of pharmaceuticals. The abili…

Recruitment agencies boost job seekers and employers by making job searches and hiring smooth and effective.
In today's competitive job market, both job seekers and employers face unique challenges. For job seekers, navigating the myriad of available roles and securing interviews can be daunting. Employers, on the other hand, struggle to identify the right candidates amidst a sea of applications. This is where recruitment agencies come into play, acting as invaluable intermediaries for both parties. Here's why using a recruitment agency is essential, whether you are looking for a job or hiring someone. Benefits for Job Seekers Access to Hidden OpportunitiesMany job openings are never advertised publicly. Recruitment agencies often have exclusive contracts with companies, giving candidates…

An electronic data capture system is a software solution designed to electronically collect, manage, and store data for clinical trials.
What is an Electronic Data Capture (EDC) System in Clinical Trials? Electronic Data Capture (EDC) systems are specialised software platforms designed to collect, manage, and store data in clinical trials. They replace traditional paper-based methods with secure, efficient, and highly accurate digital solutions. By automating data collection and streamlining management processes, EDC systems enhance data quality, minimise errors, and ensure compliance with regulatory standards. These systems are essential for modern clinical research, enabling real-time data access and integration with other clinical trial tools, thereby improving overall trial efficiency a…

AI is changing how pharmaceutical professionals work, and how you adapt is essential for long-term career success. To keep up in an AI-enhanced workplace, pharmaceutical professionals should build AI literacy without learning to code, commit to continuous learning, leverage internal training programs, and more.
Artificial intelligence (AI) is no longer a distant innovation — it's now a core part of the pharmaceutical and life sciences industries. From accelerating drug discovery to transforming regulatory processes, AI is changing how pharmaceutical professionals work.  As automation and intelligent systems become more embedded in daily operations, adapting to these changes is essential for long-term career success. Here are six ways professionals in the pharmaceutical field can reskil…

Historically cautious about adopting new technologies, the pharmaceutical industry is experiencing a remarkable transformation. Driven by competitive pressures and compelling early successes, pharma companies are increasingly embracing artificial intelligence and digital engineering to reimagine their approach to drug development, manufacturing and patient care.
Authored by Ramji Vasudevan, Head of Life Sciences and Adam Caplan, President of Digital Business and AI at Altimetrik Historically cautious about adopting new technologies, the pharmaceutical industry is experiencing a remarkable transformation. Driven by competitive pressures and compelling early successes, pharma companies are increasingly embracing artificial intelligence and digital engineering to reimagine their…

Breaking into or advancing within medical writing in the UK and Europe requires more than just a strong scientific background — employers look for candidates who can communicate complex data clearly, understand industry regulations, and collaborate effectively.
Breaking into or advancing within medical writing in the UK and Europe requires more than just a strong scientific background — employers look for candidates who can communicate complex data clearly, understand industry regulations, and collaborate effectively. This guide covers the top interview questions you're likely to encounter, with expert tips on how to answer them, and direct links to current opportunities on PharmiWeb.Jobs. 1. “Can you describe your scientific background and how it applies to medical writing?” Why they ask: …

If you’re exploring careers in the life sciences, you’ve likely come across two terms that sound similar but serve distinct functions in the pharmaceutical industry: Medical Communications and Medical Affairs. While both roles support the development and dissemination of scientific information, they do so in different ways — with different audiences, objectives, and career paths. Understanding the difference between the two can help you choose a direction that best matches your skills and long-term goals.
If you’re exploring careers in the life sciences, you’ve likely come across two terms that sound similar but serve distinct functions in the pharmaceutical industry: Medical Communications and Medical Affairs. While both roles support the development and dissemination of scientific inform…

In a bold move to reshape the landscape of pharmaceutical manufacturing in the US, President Donald Trump has signed an executive order on May 5 aimed at streamlining regulatory hurdles for domestic producers while tightening the reins on foreign manufacturers.
In a bold move to reshape the landscape of pharmaceutical manufacturing in the US, President Donald Trump has signed an executive order on May 5 aimed at streamlining regulatory hurdles for domestic producers while tightening the reins on foreign manufacturers. This directive, which instructs the FDA to expedite the approval process for US pharmaceutical facilities, has ignited a wave of skepticism within the industry regarding its potential effectiveness, says GlobalData, a leading data and analytics company. Kathryn Kinch, Senior P…

The Global Continence Care Market valued at $2.8 billion (2021), is expected to witness a growth rate of 5% in the next five years. Rising geriatric population, growing cases of spinal cord injuries, prostate enlargement, prostatectomy, spina bifida, multiple sclerosis, urinary incontinence, benign prostatic hyperplasia (BPH), kidney stones, urethra blockages, technological advancements, shift from reusable to single-use hydrophilic catheters, favorable reimbursement in key markets and improving access to healthcare in emerging markets are some of the key factors driving the continence care market growth.
The Global Continence Care Market valued at $2.8 billion (2021), is expected to witness a growth rate of 5% in the next five years. Rising geriatric population, growing cases of spina…

The Global Physiotherapy Equipment Market is expected to grow at a rate of 7% by 2026. Growing demand for rehabilitation centers, rising geriatric population, growing prevalence of neurological, musculoskeletal, and cardiovascular diseases, increasing cases of road accidents, and the rising incidence of sports injuries are some of the key factors driving the physiotherapy equipment market growth.
The Global Physiotherapy Equipment Market is expected to grow at a rate of 7% by 2026. Growing demand for rehabilitation centers, rising geriatric population, growing prevalence of neurological, musculoskeletal, and cardiovascular diseases, increasing cases of road accidents, and the rising incidence of sports injuries are some of the key factors driving the physiotherapy equipment market grow…